BACKGROUND: Barth syndrome (BTHS) is a rare X-linked disorder that is characterized by mitochondrial abnormalities, infantile or childhood onset of cardioskeletal myopathy, and high mortality rates. It is currently unknown if BTHS related mitochondrial dysfunction results in substrate metabolism abnormalities and thereby contributes to cardioskeletal myopathy in patients with BTHS. METHODS: Adolescents and young adults with BTHS (n = 5, 20 ± 4 yrs) and age and activity matched healthy controls (n = 5, 18 ± 4 yrs) underwent an hyperinsulinemic-euglycemic clamp procedure with stable isotopically labeled tracers for measurement of lipolysis, fatty acid oxidation, glucose disposal, and whole-body proteolysis rates; dual energy x-ray absorptiometry for measurement of body composition and 2-D and strain echocardiography for measurement of left ventricular function. RESULTS: Participants with BTHS had lower fat-free mass (FFM) (BTHS: 31.4 ± 6.9 vs. CONTROL: 46.7 ± 5.3 kg, p < 0.005), lower systolic function (strain, BTHS: -15.2 ± 2.4 vs. CONTROL: -19.0 ± 2.4 %, p < 0.05), greater insulin-stimulated glucose disposal rate per kg FFM (BTHS: 96.5 ± 16.3 vs. CONTROL: 67.4 ± 17.6 μmol/kgFFM/min, p < 0.05), lower basal (BTHS: 4.6 ± 2.7 vs. CONTROL: 11.9 ± 4.4 μmol/kgFM/min, p < 0.05) and hyperinsulinemic (BTHS: 1.6 ± 0.4 vs. CONTROL: 3.6 ± 1.6 μmol/kgFM/min, p < 0.05) lipolytic rate per kg fat mass (FM), and a trend towards higher basal leucine rate of appearance per kg FFM (BTHS: 271.4 ± 69.3 vs. CONTROL: 193.1 ± 28.7 μmol/kgFFM/hr, p = 0.07) compared to controls. Higher basal leucine rate of appearance per kg FFM (i.e. whole-body proteolytic rate) tended to be associated with lower left ventricular systolic strain (r = -0.57, p = 0.09). CONCLUSION: Whole-body fatty acid, glucose and amino acid metabolism kinetics when expressed per unit of body composition are altered and appear to be related to cardioskeletal myopathy in humans with BTHS. Further studies examining myocardial substrate metabolism and whole-body substrate metabolism during increased energy demands (e.g., exercise) and their relationships to skeletal and cardiac function are recommended.
BACKGROUND:Barth syndrome (BTHS) is a rare X-linked disorder that is characterized by mitochondrial abnormalities, infantile or childhood onset of cardioskeletal myopathy, and high mortality rates. It is currently unknown if BTHS related mitochondrial dysfunction results in substrate metabolism abnormalities and thereby contributes to cardioskeletal myopathy in patients with BTHS. METHODS: Adolescents and young adults with BTHS (n = 5, 20 ± 4 yrs) and age and activity matched healthy controls (n = 5, 18 ± 4 yrs) underwent an hyperinsulinemic-euglycemic clamp procedure with stable isotopically labeled tracers for measurement of lipolysis, fatty acid oxidation, glucose disposal, and whole-body proteolysis rates; dual energy x-ray absorptiometry for measurement of body composition and 2-D and strain echocardiography for measurement of left ventricular function. RESULTS:Participants with BTHS had lower fat-free mass (FFM) (BTHS: 31.4 ± 6.9 vs. CONTROL: 46.7 ± 5.3 kg, p < 0.005), lower systolic function (strain, BTHS: -15.2 ± 2.4 vs. CONTROL: -19.0 ± 2.4 %, p < 0.05), greater insulin-stimulated glucose disposal rate per kg FFM (BTHS: 96.5 ± 16.3 vs. CONTROL: 67.4 ± 17.6 μmol/kgFFM/min, p < 0.05), lower basal (BTHS: 4.6 ± 2.7 vs. CONTROL: 11.9 ± 4.4 μmol/kgFM/min, p < 0.05) and hyperinsulinemic (BTHS: 1.6 ± 0.4 vs. CONTROL: 3.6 ± 1.6 μmol/kgFM/min, p < 0.05) lipolytic rate per kg fat mass (FM), and a trend towards higher basal leucine rate of appearance per kg FFM (BTHS: 271.4 ± 69.3 vs. CONTROL: 193.1 ± 28.7 μmol/kgFFM/hr, p = 0.07) compared to controls. Higher basal leucine rate of appearance per kg FFM (i.e. whole-body proteolytic rate) tended to be associated with lower left ventricular systolic strain (r = -0.57, p = 0.09). CONCLUSION: Whole-body fatty acid, glucose and amino acid metabolism kinetics when expressed per unit of body composition are altered and appear to be related to cardioskeletal myopathy in humans with BTHS. Further studies examining myocardial substrate metabolism and whole-body substrate metabolism during increased energy demands (e.g., exercise) and their relationships to skeletal and cardiac function are recommended.
Authors: H Nørrelund; H Wiggers; M Halbirk; J Frystyk; A Flyvbjerg; H E Bøtker; O Schmitz; J O L Jørgensen; J S Christiansen; N Møller Journal: J Intern Med Date: 2006-07 Impact factor: 8.989
Authors: Yang Xu; Morgan Condell; Heide Plesken; Irit Edelman-Novemsky; Jinping Ma; Mindong Ren; Michael Schlame Journal: Proc Natl Acad Sci U S A Date: 2006-07-19 Impact factor: 11.205
Authors: Carolyn T Spencer; Barry J Byrne; Randall M Bryant; Renee Margossian; Melissa Maisenbacher; Petar Breitenger; Paul B Benni; Sharon Redfearn; Edward Marcus; W Todd Cade Journal: Am J Physiol Heart Circ Physiol Date: 2011-08-26 Impact factor: 4.733
Authors: P Vreken; F Valianpour; L G Nijtmans; L A Grivell; B Plecko; R J Wanders; P G Barth Journal: Biochem Biophys Res Commun Date: 2000-12-20 Impact factor: 3.575
Authors: Carolyn T Spencer; Randall M Bryant; Jane Day; Iris L Gonzalez; Steven D Colan; W Reid Thompson; Julie Berthy; Sharon P Redfearn; Barry J Byrne Journal: Pediatrics Date: 2006-07-17 Impact factor: 7.124
Authors: W Todd Cade; Gautam K Singh; Mark R Holland; Dominic N Reeds; E Turner Overton; Nancy Cibulka; Karen Bahow; Rachel Presti; Andrea Stephens; Alison G Cahill Journal: Clin Nutr ESPEN Date: 2015-08-01
Authors: Adam J Bittel; Kathryn L Bohnert; Dominic N Reeds; Linda R Peterson; Lisa de Las Fuentes; Manuela Corti; Carolyn L Taylor; Barry J Byrne; W Todd Cade Journal: JIMD Rep Date: 2018-04-14
Authors: Adam J Bittel; Daniel C Bittel; Bettina Mittendorfer; Bruce W Patterson; Adewole L Okunade; Jun Yoshino; Lane C Porter; Nada A Abumrad; Dominic N Reeds; W Todd Cade Journal: Diabetologia Date: 2019-12-23 Impact factor: 10.122
Authors: William Todd Cade; Kathryn L Bohnert; Linda R Peterson; Bruce W Patterson; Adam J Bittel; Adewole L Okunade; Lisa de Las Fuentes; Karen Steger-May; Adil Bashir; George G Schweitzer; Shaji K Chacko; Ronald J Wanders; Christina A Pacak; Barry J Byrne; Dominic N Reeds Journal: J Inherit Metab Dis Date: 2019-04-11 Impact factor: 4.982
Authors: Catherine H Le; Lindsay G Benage; Kalyn S Specht; Lance C Li Puma; Christopher M Mulligan; Adam L Heuberger; Jessica E Prenni; Steven M Claypool; Kathryn C Chatfield; Genevieve C Sparagna; Adam J Chicco Journal: J Biol Chem Date: 2020-07-14 Impact factor: 5.157
Authors: Michael A Kiebish; Kui Yang; Xinping Liu; David J Mancuso; Shaoping Guan; Zhongdan Zhao; Harold F Sims; Rebekah Cerqua; W Todd Cade; Xianlin Han; Richard W Gross Journal: J Lipid Res Date: 2013-02-14 Impact factor: 5.922
Authors: Silveli Suzuki-Hatano; Madhurima Saha; Skylar A Rizzo; Rachael L Witko; Bennett J Gosiker; Manashwi Ramanathan; Meghan S Soustek; Michael D Jones; Peter B Kang; Barry J Byrne; W Todd Cade; Christina A Pacak Journal: Hum Gene Ther Date: 2018-10-03 Impact factor: 5.695